Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on magnesium sulfate, ketorolac, prostigmine, or granisetron with lidocaine for intravenous regional anesthesia in forearm surgery
IRCT20141209020258N195Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine, magnesium sulfate, ketorolac, neostigmine and granisetron in procedural pain (5 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Sensory block onset time, Motor block onset time and 4 more. Started Feb 2025; status: completed.
02
Drugs
lidocainemagnesium sulfateketorolacneostigminegranisetron
03
Conditions
procedural pain
Beyond the preview
Go deeper on IRCT20141209020258N195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N195.